Vizora日本語

Nippon KayakuNIPPON KAYAKU CO.,LTD.4272東証プライム化学FY ending Mar 2026, consolidated, J-GAAP

Nippon Kayaku FY ending Mar 2022 results

About 42% of Nippon Kayaku's sales come from Functional chemicals, with Pharmaceuticals and Safety systems making up much of the rest.

Out of every ¥100 of sales, about ¥12 is left as operating profit.

Revenue changed +6.6% from the prior year, operating profit +38.5%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +6.6% · profit +38.5%, calculated from disclosed figures.

Operating leverage: 5.85× (profit growth ÷ revenue growth)

What changed from last year

FY ending Mar 2021 → FY ending Mar 2022

Revenue
+6.6%¥173.4B → ¥184.8B
Gross profit
+13.6%¥56.3B → ¥64B
Operating income
+38.5%¥15.2B → ¥21.1B
Net income attributable to owners
+36.6%¥12.6B → ¥17.2B
Operating cash flow
-5.2%¥24.4B → ¥23.1B
Free cash flow
+25.1%¥11.2B → ¥14B

Where the money goes

FY ending Mar 2021 → FY ending Mar 2022

Where ¥100 of sales goes

For every ¥100 Nippon Kayaku sells, how much goes where, and how much is kept.

FY ending Mar 2022
Cost of sales
¥65
SG&A
¥23
Operating profit
¥12
Net profit kept
¥9

Annual margin trends

Gross margin34.6%
FY ending Mar 2020: 33.2%33.2%FY ending Mar 2021: 32.5%32.5%FY ending Mar 2022: 34.6%34.6%FY20FY21FY22
Operating margin11.4%
FY ending Mar 2020: 10.0%10.0%FY ending Mar 2021: 8.8%8.8%FY ending Mar 2022: 11.4%11.4%FY20FY21FY22
Net margin9.3%
FY ending Mar 2020: 7.3%7.3%FY ending Mar 2021: 7.3%7.3%FY ending Mar 2022: 9.3%9.3%FY20FY21FY22

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2022
  • Functional chemicals¥77.2B
    42%
    Op. margin 14.9%
  • Pharmaceuticals¥52.1B
    28%
    Op. margin 16.6%
  • Safety systems¥46.1B
    25%
    Op. margin 13.7%
  • Other¥9.46B
    5%
    Op. margin 19.5%

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第169期(2025/04/01－2026/03/31)

    ID S100YD4R2026-06-19Open

  • EDINET (FSA Japan)

    有価証券報告書－第168期(2024/04/01－2025/03/31)

    ID S100W41Y2025-06-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第167期(2023/04/01－2024/03/31)

    ID S100TTFJ2024-06-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第166期(2022/04/01－2023/03/31)

    ID S100QY0D2023-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第165期(令和3年4月1日－令和4年3月31日)

    ID S100ODM32022-06-28Open

  • EDINET (FSA Japan)

    有価証券報告書－第164期(令和2年4月1日－令和3年3月31日)

    ID S100LN1F2021-06-25Open

Extracted from XBRL: 55 / Derived from other figures: 2

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image